OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022
OPKO Health, Inc. (NASDAQ: OPK) will report its financial results for Q1 2022 on May 9, 2022, after U.S. market close. The company's senior management will discuss the results and provide financial guidance during a live conference call at 4:30 PM ET. Participants can pre-register for the call and access a webcast on OPKO's Investor Relations page. A replay will be available until May 16, 2022. For further information about OPKO's operations and market position, visit their official website.
- None.
- None.
MIAMI, May 05, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2022 after the close of the U.S. financial markets on Monday, May 9, 2022. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 9th beginning at 4:30 p.m. Eastern time.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will be given a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing (866) 777-2509 (U.S.) or (412) 317-5413 (International). A webcast of the call may also be accessed at OPKO’s Investor Relations page and here.
A telephone replay will be available until May 16, 2022 by dialing (877) 344-7529 (U.S.) or (412) 317-0088 (International) and providing the passcode 6587528. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
FAQ
When will OPKO Health release its Q1 2022 financial results?
What time is the OPKO Health conference call for Q1 2022 results?
How can I participate in the OPKO Health conference call?
Will there be a replay of the OPKO Health Q1 2022 conference call?
